A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better.
Saved in:
| Title: | A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better. |
|---|---|
| Authors: | Djureinovic D; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Weiss SA; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Krykbaeva I; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Qu R; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Vathiotis I; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Moutafi M; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Zhang L; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Perdigoto AL; Department of Internal Medicine, Yale University, New Haven, CT, USA., Wei W; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA., Anderson G; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Damsky W; Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA., Hurwitz M; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Johnson B; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Schoenfeld D; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Mahajan A; Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA., Hsu F; Apexigen, Inc., San Carlos, CA, USA., Miller-Jensen K; Department of Biomedical Engineering, Yale University, New Haven, CT, USA.; Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA.; Systems Biology Institute, Yale University, New Haven, CT, USA., Kluger Y; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Sznol M; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Kaech SM; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute, La Jolla, CA, USA., Bosenberg M; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.; Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA., Jilaveanu LB; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA., Kluger HM; Department of Medicine (Medical Oncology), Yale University School of Medicine, 333 Cedar Street, WWW211B, New Haven, CT, 06520, USA. Harriet.Kluger@yale.edu. |
| Source: | Molecular cancer [Mol Cancer] 2023 Nov 14; Vol. 22 (1), pp. 182. Date of Electronic Publication: 2023 Nov 14. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1476-4598 |
|---|---|
| DOI: | 10.1186/s12943-023-01884-x |
